Data / Drug companies / Potassium Salt
Potassium Salt drugs: 57 drugs from 153 companies in the FDA NDC directory
Potassium Salt is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 798 products in this class from 153 companies, covering 57 drugs by generic name. The main marketing category is unapproved homeopathic products, and the newest product started marketing on October 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 153Companies
- 798Products
- 57Drugs by generic name
Drugs in the Potassium Salt class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Potassium chloride | 256 | 84 |
| Potassium chloride extended-release | 22 | 13 |
| Kali phosphoricum | 17 | 9 |
| Kali muriaticum | 15 | 8 |
| Kali sulphuricum | 6 | 8 |
| Magnesia phosphorica | 1 | 8 |
| Potassium phosphates | 13 | 6 |
| Sodium sulfate, potassium sulfate, magnesium sulfate | 8 | 6 |
| Potassium sulfate | 10 | 4 |
| Potassium chloride oral | 4 | 4 |
| Potassium acetate | 7 | 3 |
| Sodium chloride and potassium chloride | 7 | 3 |
| Potassium chloride for oral solution | 5 | 3 |
| Potassium phosphate, monobasic potassium phosphate, dibasic | 5 | 3 |
| Potassium phosphate, dibasic | 2 | 3 |
| Sodium sulfate, potassium sulfate and magnesium sulfate | 1 | 3 |
| Potassium bicarbonate | 5 | 2 |
| Potassium phosphate | 3 | 2 |
| Calc fluor, ferr phos, kali mur, kali phos. | 2 | 2 |
| Ferr phos, kali sulf, mag phos, nat sulf. | 2 | 2 |
| Kalium muriaticum icing sugar | 2 | 2 |
| Kalium sulphuricum icing sugar | 2 | 2 |
| Sodium chloride, potassium chloride, and calcium chloride | 2 | 2 |
| Sodium sulfate, magnesium sulfate, and potassium chloride | 2 | 2 |
| Cough drops | 1 | 2 |
| Kali phos | 1 | 2 |
| Laxative | 1 | 2 |
| Sodium sulfate, potassium sulfate and magnesium sulfate oral | 1 | 2 |
| Kali aceticum | 16 | 1 |
| Kali chloricum | 8 | 1 |
| Kali ferrocyanatum | 8 | 1 |
| Kali fluoratum | 8 | 1 |
| Kali oxalicum | 8 | 1 |
| Kali tartaricum | 8 | 1 |
| Kali telluricosum | 8 | 1 |
| Potassium chloride, dextrose monohydrate and sodium chloride | 8 | 1 |
| Dextrose, sodium chloride, and potassium chloride | 6 | 1 |
| Potassium chloride and sodium chloride | 3 | 1 |
| Potassium chloride er | 3 | 1 |
| Kali muriaticum,kali sulphuricum,calcarea sulphurica,silicea | 2 | 1 |
| Potassium chlorate | 2 | 1 |
| Potassium chloride, dextrose monohydrate | 2 | 1 |
| Alka-seltzer gold | 1 | 1 |
| Calc phos, ferr phos, kali mur. | 1 | 1 |
| Calc sulph, kali sulph, silicea | 1 | 1 |
| Dextrose and potassium chloride | 1 | 1 |
| Ferrum phos, kalii sulph, nat phos. | 1 | 1 |
| Kali bic, kali mur, kali sulph | 1 | 1 |
| Kali muriaticum, prunus spinosa, silicea, sarsaparilla | 1 | 1 |
| Kali silicatum | 1 | 1 |
| Kalium muriaticum | 1 | 1 |
| Kalium sulphuricum | 1 | 1 |
| Potassium chloride and dextrose monohydrate | 1 | 1 |
| Potassium phosphates in sodium chloride | 1 | 1 |
| Potassium tetrachloroaurate dihydrate | 1 | 1 |
| Sodium chloride, calcium chloride, potassium chloride, | 1 | 1 |
| Wood creosote, potassium sulfate, and araneus diadematus | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Hahnemann Laboratories, Inc. | 89 | pellet | Unapproved homeopathic products | September 14, 2023 |
| Fresenius Kabi USA, LLC | 30 | injection, solution; injection | Generic drugs (ANDA) | June 15, 2025 |
| Baxter Healthcare Corporation | 26 | injection, solution; irrigant | New drug applications (NDA) | November 8, 2024 |
| A-S Medication Solutions | 24 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | November 14, 2023 |
| Icu Medical Inc. | 24 | injection, solution; irrigant | New drug applications (NDA) | February 8, 2021 |
| Boiron | 22 | pellet | Unapproved homeopathic products | January 1, 2025 |
| B. Braun Medical Inc. | 21 | injection, solution; injection | New drug applications (NDA) | October 1, 2026 |
| Deseret Biologicals, Inc. | 16 | liquid | Unapproved homeopathic products | January 5, 2026 |
| BM Private Limited | 15 | globule; liquid | Unapproved homeopathic products | January 1, 2015 |
| BioActive Nutritional, Inc. | 15 | liquid | Unapproved homeopathic products | March 20, 2025 |
| Total Operations Management LLC DBA:Bestmade Natural Products Micro | 15 | globule; tablet | Unapproved homeopathic products | June 1, 2026 |
| Professional Complementary Health Formulas | 14 | liquid | Unapproved homeopathic products | August 15, 1984 |
| Ohm Pharma Inc. | 13 | liquid; gel | Unapproved homeopathic products | November 20, 2017 |
| Bryant Ranch Prepack | 12 | tablet, extended release | Generic drugs (ANDA) | April 10, 2023 |
| Siddha Flower Essences LLC | 12 | spray | Unapproved homeopathic products | May 6, 2015 |
| Talbot's Pharmaceuticals Family Products, LLC. | 12 | liquid; tablet, soluble | Unapproved homeopathic products | September 28, 2022 |
| Apex Energetics Inc. | 11 | solution/ drops | Unapproved homeopathic products | March 22, 2022 |
| Newton Laboratories, Inc. | 11 | liquid; pellet | Unapproved homeopathic products | January 31, 2024 |
| Dna Labs, Inc. | 10 | solution | Unapproved homeopathic products | January 1, 1990 |
| Energique, Inc. | 10 | liquid | Unapproved homeopathic products | January 28, 2025 |
| Fresenius Kabi USA, LLC | 10 | injection, solution; injection, emulsion | Generic drugs (ANDA) | June 2, 2021 |
| Hospira, Inc. | 10 | injection, solution, concentrate; injection, solution | New drug applications (NDA) | September 29, 2025 |
| Martin & Pleasance Pty Ltd | 10 | tablet, chewable; spray | Unapproved homeopathic products | September 1, 2025 |
| Silver Star Brands | 10 | liquid; spray | Unapproved homeopathic products | April 3, 2023 |
| Advagen Pharma Ltd | 9 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | August 22, 2024 |
| Aphena Pharma Solutions - Tennessee, LLC | 9 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | August 8, 2025 |
| Upsher-Smith Laboratories, LLC | 9 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | August 15, 2025 |
| Granules Pharmaceuticals Inc. | 8 | tablet, extended release; capsule, extended release | Generic drugs (ANDA) | April 25, 2021 |
| Lupin Pharmaceuticals,Inc. | 7 | powder, for solution; tablet, extended release | Generic drugs (ANDA) | September 24, 2018 |
| Major Pharmaceuticals | 7 | tablet, extended release; solution | Generic drugs (ANDA) | February 4, 2026 |
| Vantive US Healthcare LLC | 7 | injection | New drug applications (NDA) | January 13, 2015 |
| American Health Packaging | 6 | tablet, extended release; solution | Generic drugs (ANDA) | March 30, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 6 | capsule, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | November 14, 2023 |
| Remedyrepack Inc. | 6 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | November 21, 2025 |
| Strides Pharma Science Limited | 6 | powder, for solution; tablet, extended release | Generic drugs (ANDA) | January 10, 2019 |
| Amneal Pharmaceuticals Private Limited | 5 | solution, concentrate | Generic drugs (ANDA) | July 9, 2025 |
| Aurobindo Pharma Limited | 5 | tablet, extended release; solution | Generic drugs (ANDA) | November 20, 2025 |
| BluePoint Laboratories | 5 | tablet; capsule, extended release | Generic drugs (ANDA) | July 10, 2024 |
| Bryant Ranch Prepack | 5 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | June 17, 2020 |
| Camber Pharmaceuticals, Inc. | 5 | tablet, extended release; solution | Generic drugs (ANDA) | December 26, 2024 |
| Macleods Pharmaceuticals Limited | 5 | solution; tablet, film coated, extended release | Generic drugs (ANDA) | August 31, 2026 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 5 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | August 7, 2023 |
| PureTek Corporation | 5 | tablet | Other unapproved drugs | October 11, 2024 |
| Solco Healthcare US, LLC | 5 | tablet; capsule, extended release | Generic drugs (ANDA) | April 30, 2019 |
| Affordable Pharmaceuticals, LLC | 4 | solution, concentrate; powder, for solution | New drug applications (NDA) | February 8, 2013 |
| AvKARE | 4 | tablet, extended release; capsule, extended release | Generic drugs (ANDA) | August 8, 2025 |
| Azurity Pharmaceuticals, Inc. | 4 | solution, concentrate; tablet | New drug applications (NDA) | April 17, 2026 |
| Braintree Laboratories, Inc. | 4 | solution, concentrate; tablet | New drug applications (NDA) | November 10, 2020 |
| Direct_Rx | 4 | tablet, extended release | Generic drugs (ANDA) | November 4, 2025 |
| Granules India Limited | 4 | capsule, extended release; tablet | Generic drugs (ANDA) | January 1, 2023 |
| HF Acquisition Co LLC, DBA HealthFirst | 4 | injection, solution; injection, solution, concentrate | New drug applications (NDA) | May 21, 2020 |
| Nomax Inc. | 4 | tablet, effervescent | Other unapproved drugs | January 30, 2013 |
| Northwind Health Company, LLC | 4 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | October 25, 2022 |
| Pai Holdings, LLC DBA Pai Pharma | 4 | solution | Generic drugs (ANDA) | March 27, 2023 |
| Proficient Rx LP | 4 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | August 7, 2023 |
| Slate Run Pharmaceuticals, LLC | 4 | tablet, film coated, extended release | Generic drugs (ANDA) | February 1, 2020 |
| Sun Pharmaceutical Industries, Inc. | 4 | capsule, extended release; tablet, extended release | Generic drugs (ANDA) | November 14, 2023 |
| Upsher-Smith Laboratories, LLC | 4 | tablet, film coated, extended release; tablet, extended release | New drug applications (NDA) | November 20, 1998 |
| Upsher-Smith Laboratories, LLC | 4 | tablet, extended release | Generic drugs (ANDA) | October 28, 2024 |
| Vitality Works, Inc. | 4 | liquid | Unapproved homeopathic products | April 8, 2013 |
| Wilshire Pharmaceuticals, Inc. | 4 | powder, for solution; solution, concentrate | Authorized generics (NDA) | April 15, 2026 |
| Ajenat Pharmaceuticals LLC | 3 | solution; powder, for solution | Generic drugs (ANDA) | March 23, 2026 |
| American Regent, Inc. | 3 | injection, solution | Generic drugs (ANDA) | October 13, 2023 |
| Atlantic Biologicals Corp. | 3 | solution; tablet, extended release | Generic drugs (ANDA) | October 5, 2023 |
| AvPAK | 3 | solution; capsule, extended release | Generic drugs (ANDA) | January 26, 2023 |
| Bpi Labs LLC | 3 | solution; powder, for solution | Generic drugs (ANDA) | July 4, 2023 |
| Bryant Ranch Prepack | 3 | tablet, extended release; capsule, extended release | Generic drugs (ANDA) | January 1, 2021 |
| Caplin Steriles Limited | 3 | injection, solution, concentrate | Generic drugs (ANDA) | September 17, 2026 |
| Cardinal Health 107, LLC | 3 | powder, for solution; solution | Generic drugs (ANDA) | August 24, 2026 |
| Carwin Pharmaceutical Associates, LLC | 3 | powder, for solution; liquid | New drug applications (NDA) | January 14, 2026 |
| Cipla USA Inc. | 3 | injection | Generic drugs (ANDA) | February 6, 2025 |
| Epic Pharma, LLC | 3 | tablet, film coated, extended release; powder, for solution | Generic drugs (ANDA) | August 7, 2023 |
| Glenmark Pharmaceuticals Inc., USA | 3 | injection, solution, concentrate | Generic drugs (ANDA) | March 12, 2026 |
| Guardian Drug Company | 3 | solution; powder, for solution | Generic drugs (ANDA) | July 22, 2025 |
| Hyland's Inc. | 3 | tablet; tablet, soluble | Unapproved homeopathic products | December 6, 2021 |
| Marlex Pharmaceuticals, Inc. | 3 | solution; powder, for solution | Generic drugs (ANDA) | August 1, 2025 |
| Natural Creations, Inc | 3 | liquid | Unapproved homeopathic products | February 7, 2019 |
| Nexus Pharmaceuticals LLC | 3 | injection | Generic drugs (ANDA) | February 28, 2021 |
| Nutritional Specialties, Inc. | 3 | spray; liquid | Unapproved homeopathic products | October 9, 2023 |
| Redpharm Drug | 3 | tablet, extended release | Generic drugs (ANDA) | January 30, 2021 |
| Seroyal USA | 3 | tablet | Unapproved homeopathic products | May 3, 2018 |
| XLCare Pharmaceuticals, Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | March 4, 2021 |
| Zydus Pharmaceuticals USA Inc. | 3 | capsule, extended release; tablet, extended release | Generic drugs (ANDA) | February 3, 2022 |
| Adare Pharmaceuticals Inc | 2 | capsule | Generic drugs (ANDA) | April 1, 2018 |
| Alcon Laboratories, Inc. | 2 | solution | New drug applications (NDA) | March 28, 1969 |
| Amneal Pharmaceuticals NY LLC | 2 | solution | Generic drugs (ANDA) | July 24, 2018 |
| Applied Bioenergetics, LLC | 2 | tablet, chewable | Unapproved homeopathic products | September 27, 2024 |
| Asclemed USA, Inc. | 2 | injection, solution | New drug applications (NDA) | June 24, 2019 |
| Aurobindo Pharma Limited | 2 | tablet, film coated, extended release | Generic drugs (ANDA) | December 19, 2018 |
| Bhp Holdings, Inc. | 2 | liquid | Unapproved homeopathic products | June 1, 2023 |
| Cranbury Pharmaceuticals, LLC | 2 | solution | Generic drugs (ANDA) | January 26, 2022 |
| Dr. Reddy's Laboratories Inc. | 2 | solution | Generic drugs (ANDA) | July 25, 2022 |
| Genus Lifesciences | 2 | powder, for solution; solution | New drug applications (NDA) | September 7, 2015 |
| Henry Schein, Inc. | 2 | injection, solution, concentrate | Generic drugs (ANDA) | January 13, 2022 |
| JoyWell Co LLC | 2 | pellet; liquid | Unapproved homeopathic products | November 19, 2025 |
| Kesin Pharma Corporation | 2 | solution | Generic drugs (ANDA) | August 15, 2022 |
| Mylan Pharmaceuticals Inc. | 2 | tablet, film coated, extended release | Generic drugs (ANDA) | November 9, 2016 |
| Northwind Health Company, LLC | 2 | tablet, extended release | Generic drugs (ANDA) | June 12, 2026 |
| Novel Laboratories, Inc. | 2 | for solution; powder, for solution | Generic drugs (ANDA) | November 21, 2018 |
| Preferred Pharmaceuticals Inc. | 2 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | September 19, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Pellet | 124 | 15.5% |
| Liquid | 115 | 14.4% |
| Tablet, extended release | 102 | 12.8% |
| Injection, solution | 88 | 11% |
| Solution | 65 | 8.1% |
| Tablet, film coated, extended release | 49 | 6.1% |
| Tablet | 32 | 4% |
| Powder, for solution | 30 | 3.8% |
| Injection, solution, concentrate | 28 | 3.5% |
| Injection | 28 | 3.5% |
| Capsule, extended release | 25 | 3.1% |
| Spray | 25 | 3.1% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.